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Introduction {#sec1}
============

Glucocorticoids (GCs) are clinically important metabolic hormones with powerful anti-inflammatory effects. They are among the most widely prescribed therapeutic agents, but cardio-metabolic side effects and resistance limit their therapeutic use. Furthermore, GC resistance emerges in many patients with chronic inflammatory disease, and the basis of the lack of efficacy in acute inflammation associated with sepsis is not well understood ([@bib9], [@bib36]). Dysregulation of endogenous GCs during severe illness has been linked to worse outcomes ([@bib2], [@bib6]).

GCs act by binding to the glucocorticoid receptor (GR) (*Nr3c1*), which is a ligand-activated transcription factor (TF). Macrophages express GR at high levels ([@bib13], [@bib24]) and are major targets of the anti-inflammatory and therapeutic impacts of GC treatment ([@bib22], [@bib30]). Although there is evidence for direct trans-repression of pro-inflammatory genes by GCs ([@bib46]), the major mechanism of action appears to involve induction of feedback regulators, such as *Dusp1*, *IkBa*, *Tnfaip3*, and *Tsc22d3* ([@bib22], [@bib30], [@bib35], [@bib47]). As an inducer of gene expression, GR binds in a ligand-dependent manner to DNA at sites (enhancers) that may lie many tens of kilobases from the target gene ([@bib25], [@bib22], [@bib35], [@bib41], [@bib44], [@bib46]). GR binding is largely constrained to sites accessible to nuclease digestion and is associated with the nearby binding sites for pioneer TFs ([@bib4], [@bib5], [@bib15], [@bib22], [@bib43]). As a consequence, GR target genes can vary between tissue and cell types. In the case of macrophages, GR binding is strongly associated with binding sites for the macrophage lineage TF PU.1 ([@bib22], [@bib30]), and further binding sites become available upon inflammatory activation, associated with AP1 and RelA binding ([@bib30]). The transcriptional response of macrophages to GCs varies markedly between humans and mice, associated with the gain and loss of GR binding sequence motifs ([@bib22]). GR binding can also initiate the formation of a more nuclease-sensitive local chromatin structure ([@bib5], [@bib7], [@bib19], [@bib16], [@bib44]). This may be transient, disappearing rapidly upon hormone withdrawal, or may persist well beyond the period of hormone treatment ([@bib44]).

As well as altering local nucleosome structure, some nuclear hormone receptors, such as the estrogen receptor, can modulate chromatin structure at a scale sufficiently large to be detectable by light microscopy ([@bib29], [@bib34]). There have been few reports on GR actions at this level of chromosome structure. At a repetitive array of the mouse mammary tumor virus (MMTV) promoter, GR binding results in transcription-dependent visible chromatin decompaction over the course of a few hours ([@bib26]). Conversely, 4C chromatin conformation capture assays of the GR-responsive *Lcn2* locus in a mammary adenocarcinoma cell line indicated that GR binding produced only a modest effect on long-range chromatin contacts captured with this approach ([@bib16]).

We previously identified inducible sites of GR binding at likely enhancers of genes induced by GC in primary mouse and human macrophages ([@bib22]). Here, using fluorescence *in situ* hybridization (FISH), we demonstrate rapid, persistent, and visible chromatin decompaction---increases in inter-probe distances---at multiple GC-responsive loci in mouse bone-marrow-derived macrophages (mBMDMs) following dexamethasone treatment. We compare and contrast the behavior of loci in which the GC response is conserved in mice and humans with loci whose response to GC is specific to mouse macrophages. Our data provide insight into how GCs affect large-scale chromatin structure in macrophages and indicate that there may be a long-term "memory" of GR binding on chromatin.

Results {#sec2}
=======

GC Induces Rapid GR Binding at Enhancers at the *Fkbp5* Locus {#sec2.1}
-------------------------------------------------------------

We have previously generated genome-wide expression and GR binding data in primary mouse and human macrophages responding to 100 nM dexamethasone (Dex), a GR agonist ([@bib22]). These GR binding sites bear the hallmarks of enhancers, being enriched in PU.1 binding sites, and active enhancer histone marks in unstimulated mBMDMs ([@bib31]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Many GC-inducible genes were regulated only in one species or the other, associated with gain and loss of GR motifs from the respective genome. Even for genes that were induced in both species, the precise site of GR binding was not always conserved. In this study, we first focused on *Fkbp5*, a GR co-chaperone and inducible feedback regulator of the GC response. Elevated Fkbp5 levels reduce the affinity of GR for the agonist and are associated with resistance ([@bib10], [@bib18], [@bib47], [@bib51]).

*Fkbp5* is strongly induced by Dex in both mouse and human macrophages. The time course of *Fkbp5* mRNA induction in BMDMs is shown in [Figure 1](#fig1){ref-type="fig"}A. In human A549 lung carcinoma cells, GR binding sites have been described 34 kb 5′ and 87 kb 3′ of the *FKBP5* transcription start site (TSS) ([@bib35]). In human macrophages, we also identified two major GR binding sites in similar locations ([@bib22]). In mBMDMs, chromatin immunoprecipitation sequencing (ChIP-seq) revealed strong GR binding at a site 28 kb upstream of *Fkbp5* (−28 kb) and at an intragenic site (+65 kb) after 1 hr of Dex exposure ([Figure 1](#fig1){ref-type="fig"}B). As seen for most GC-responsive genes in macrophages from both species ([@bib22]), no GR binding was detected at the *Fkbp5* promoter. Both GR enhancer locations in the two species correspond to putative enhancers based upon the bidirectional transcription of enhancer-associated enhancer RNA (eRNA) ([@bib1]). The kinetics of GR binding and loading of chromatin remodeling complexes in cell lines indicate that conformational changes induced by GC may be rapid---within minutes ([@bib21], [@bib27], [@bib48]). To examine these kinetics in macrophages, we measured GR binding at the *Fkbp5* locus over a 1-hr time course. There was evidence of GR binding at either enhancer within 5 min of Dex addition. Maximal binding at the −28-kb element occurred by 15 min ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B), while binding at +65 kb had slower kinetics, being detectable by 15 min and increasing 1 hr after Dex addition.Figure 1GC Causes Rapid and Prolonged Chromatin Decompaction at the *Fkbp5* Locus(A) Expression data in response to 100 nM dexamethasone (Dex) for *Fkbp5* at the time points indicated ([@bib22]). Dx, treated for 2 hr, then washout for 22 hr; V, vehicle treated and washout 22 hr. Yellow rectangle highlights the static level of stable mRNA by 1 hr. Expression is presented as the raw normalized intensity values from microarrays.(B) Genome browser image showing *Fkbp5* locus with ChIP-seq data (tags/bp) for GR binding from [@bib22]. Red and green blocks show the positions of FISH probes. Genome map positions are from the mm9 assembly of the mouse genome. Positions of primers used for ChIP-qPCR are shown (+65 kb, promoter, −28 kb).(C) Glucocorticoid receptor (GR) binding measured by ChIP-qPCR for the downstream enhancer (+65 kb), promoter and upstream enhancer (−28 kb) of *Fkbp5* and a control site in the *Actb* promoter. Data are shown for a four-point time series (baseline, 5 min, 15 min,1 hr) of treatment with 100 nM Dex. IgG control ChIP is also shown. Error bars are 2× SEM for three technical replicates (a further biological replicate is shown in [Figure S1](#mmc1){ref-type="supplementary-material"}B).(D) 3D DNA FISH images of nuclei from mBMDM treated with 100 nM Dex or vehicle control for 5 min using the probes indicated in (A). Scale bar represents 1 μm.(E) Boxplots of inter-probe distances (μm) measured across the *Fkbp5* locus at the indicated times following treatment with vehicle or 100 nM Dex; n = 80 for each condition. Horizontal line, median; whiskers, 1.5× interquartile range; ^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.0005, Wilcoxon rank sum.(F) As for (E) but after culturing for prolonged periods after Dex washout.(G) GR binding measured by ChIP-qPCR for the *Fkbp5* downstream enhancer (+65 kb) and *Actb* promoter following stimulation with 100 nM Dex at 1 and 24 hr with (1h+23w) and without (24h) washout of the ligand. Error bars are 2× SEM for three technical replicates (a further biological replicate is shown in [Figure S1](#mmc1){ref-type="supplementary-material"}C).

GR Binding Is Associated with Rapid and Persistent Chromatin Decompaction at *Fkbp5* {#sec2.2}
------------------------------------------------------------------------------------

To better understand the relationship between GR binding and long-range chromatin structure, we analyzed chromatin compaction by 3D DNA-FISH ([@bib12], [@bib50]) using one probe overlapping the −28-kb enhancer and extending to the *Fkbp5* promoter, and another lying just beyond the +65-kb enhancer ([Figure 1](#fig1){ref-type="fig"}B). Following Dex treatment of mBMDMs, there was a rapid (\<5-min) increase in the average inter-probe distances measured across the *Fkbp5* locus ([Figures 1](#fig1){ref-type="fig"}D and 1E). We will refer to this phenomenon as locus decompaction. [Figure S2](#mmc1){ref-type="supplementary-material"} shows further illustrative images, with and without Dex treatment, from each of the loci tested here. Chromatin decompaction across the *Fkbp5* locus preceded detectable increased stable *Fkbp5* mRNA production ([Figure 1](#fig1){ref-type="fig"}A) and was maintained even after 24 hr ([Figure 1](#fig1){ref-type="fig"}E). To determine whether chromatin decompaction persists beyond the initial exposure period, Dex was washed out from the culture medium. *Fkbp5* mRNA levels returned to near baseline within 24 hr of washout ([Figure 1](#fig1){ref-type="fig"}A). However, chromatin decompaction persisted for 5 days after ligand washout ([Figure 1](#fig1){ref-type="fig"}F). Surprisingly, ChIP showed that GR binding at the +65-kb enhancer is transient, decaying completely after 24 hr, regardless of whether Dex was washed out after 1 hr ([Figures 1](#fig1){ref-type="fig"}G and [S1](#mmc1){ref-type="supplementary-material"}C). These data suggest that GR binding has a direct and long-lasting effect on large-scale chromatin structure at the *Fkbp5* locus that occurs before the appearance of *Fkbp5* mRNA and persists after *Fkbp5* mRNA is no longer produced, and after GR binding is lost.

Chromatin Decompaction Is Slow and Transient at a GC-Responsive Locus Where GR Is Not Bound {#sec2.3}
-------------------------------------------------------------------------------------------

Most, but not all, GC-inducible genes in mBMDMs have detectable GR bound in their vicinity (±1,000 kb) ([@bib22]). For responsive genes without detectable GR binding in the general vicinity, transcriptional activation is likely to be a secondary consequence of GC induction of TFs. Eight of the GC-inducible genes in macrophages encode TFs, including four (*Fos*, *Hivep2*, *Klf4*, and *NcoA5*) that were induced within 2 hr and might contribute to downstream target gene induction. The *Tmod1* locus, which shares the same kinetics of gene activation in response to Dex as *Fkbp5* ([Figure 2](#fig2){ref-type="fig"}A), did not show evidence of regulated GR binding anywhere within its immediate vicinity ([Figure 2](#fig2){ref-type="fig"}B), or indeed anywhere within the wider Mb domain that likely encompasses an entire topologically associated domain ([Figure S3](#mmc1){ref-type="supplementary-material"}) ([@bib11]). By contrast to the rapid and sustained effect at *Fkbp5*, FISH indicated that chromatin decompaction across the *Tmod1* locus in response to GC occurred more slowly (1--4 hr), paralleled the kinetics of mRNA induction, and was not sustained at 24 hr ([Figures 2](#fig2){ref-type="fig"}C and 2D).Figure 2Delayed and Transient Chromatin Decompaction in Response to GC at *Tmod1*(A) Expression data in response to 100 nM Dex for *Tmod1* at the time points indicated ([@bib22]). Expression is presented as the raw normalized intensity values from microarrays.(B) Genome browser image showing GR ChIP-seq data for *Tmod1* locus ([@bib22]) and the position of probes used for DNA FISH.(C) 3D DNA FISH images of nuclei from mBMDM 4 hr after treatment with vehicle or 100 nM Dex using the probes indicated in (B). Scale bar represents 1 μm.(D) Inter-probe distances (μm) measured across *Tmod1* locus at the indicated times following treatment with 100 nM Dex; n = 80 for each condition. Boxplots shown as in [Figure 1](#fig1){ref-type="fig"}.

Rapid Chromatin Decompaction Occurs at Multiple Loci {#sec2.4}
----------------------------------------------------

*Fkbp5* has a specific role in feedback control of the response to GCs, and so could have a unique mode of regulation. We therefore analyzed several other GR-bound loci that differ in whether the response to GC was conserved across species. One of these is a large (720-kb) cluster of genes for the tetraspanin family of transmembrane proteins (referred to here as *Ms4xxx*). A peak of Dex-induced GR binding is located in the center of the *Ms4xxx* cluster, between *Ms4a7* and *Ms4a4c* ([Figure 3](#fig3){ref-type="fig"}B). Interestingly, *Ms4a4c* and *Ms4a4b*, close to the GR binding site, are not induced by GC, but the more distant *Ms4a6b*, *Ms4a6c*, and *Ms4a6d* were significantly induced by Dex, albeit more slowly than for *Fkbp5* ([Figure 3](#fig3){ref-type="fig"}A). Ms4a family members were also induced in human macrophages, also associated with GR binding to the locus ([@bib22]). Despite the slower kinetics of gene induction, FISH revealed that, as seen at *Fkbp5*, there was rapid (within 5 min) and sustained chromatin decompaction across the central part of the *Ms4xxx* locus after Dex treatment ([Figures 3](#fig3){ref-type="fig"}C and 3D and [S2](#mmc1){ref-type="supplementary-material"}).Figure 3Rapid and Sustained Chromatin Decompaction in Response to GC at a Multi-gene Locus(A) Expression time course data for the GC-regulated genes in the *Ms4xxx* locus. Expression is presented as the raw normalized intensity values from microarrays.(B) Genome browser image showing GR ChIP-seq data from mBMDM for *Ms4xxx* locus ([@bib22]) and the position of probes used for DNA FISH.(C) 3D DNA FISH images of nuclei from mBMDM 15 min after treatment with vehicle or 100 nM Dex, using the probes indicated in (B). Scale bar represents 1 μm.(D) Inter-probe distances (μm) measured across the *Ms4xxx* locus at the indicated times following treatment with 100 nM Dex; n = 80 for each condition. Boxplots shown as in [Figure 1](#fig1){ref-type="fig"}.

A third example of a conserved GR-inducible locus was *Klhl6/B3gnt5/Klhl24* ([Figure S4](#mmc1){ref-type="supplementary-material"}A), where all three transcripts were induced by Dex. Here again, we observed rapid locus decompaction upon addition of Dex that was sustained for at least 24 hr ([Figures 4](#fig4){ref-type="fig"}A and 4B, images from further time points are shown in [Figure S2](#mmc1){ref-type="supplementary-material"}).Figure 4Rapid and Sustained Chromatin Decompaction May Be a Feature of Loci That Are Conserved in Their GC Response(A) 3D DNA FISH images at the *Klhl6/B3gnt5 locus* of nuclei from mBMDMs 15 min after treatment with vehicle or 100 nM Dex. Probe positions shown in [Figure S4](#mmc1){ref-type="supplementary-material"}A. Scale bar represents 1 μm.(B--D) Boxplots of the inter-probe distances (μm) measured across the *Klhl6/B3gnt5* (B), *Tns1* (C), and *Dst* (D) loci at the indicated times following treatment with vehicle or 100 nM Dex; n = 120 for each condition. Boxplots as in [Figure 1](#fig1){ref-type="fig"}.(E) GR binding measured by ChIP-qPCR at *Tns1* and *Ms4xxx* loci and *Actb* promoter following stimulation with 100 nM Dex. Data are shown for 1 and 24 hr with (1h+23w) and without (24h) washout of the ligand. Error bars are 2× SEM for three technical replicates (a biological replicate is shown in [Figure S5](#mmc1){ref-type="supplementary-material"}).

We speculated that genes induced by GC only in one species (mouse or human), but not both, might exhibit distinct modes of induction. Accordingly, we examined two loci---*Tns1*, which had a local GR peak, and *Dst*, which did not---induced by Dex in mBMDMs but not in human monocyte-derived macrophages ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). Dex induced rapid chromatin decompaction at these two loci, but by contrast with loci with conserved GC responses between species, this was not sustained beyond the first 5 min ([Figures 4](#fig4){ref-type="fig"}C and 4D).

As observed at the *Fkbp5* (+65) enhancer, the sustained chromatin decompaction observed at the *Ms4xxx* locus was not associated with continuous GR binding. GR binding was undetectable at both the *Ms4xxx* and *Tns1* loci after 24 hr, regardless of whether or not the agonist was washed out after 1 hr ([Figures 4](#fig4){ref-type="fig"}E and [S5](#mmc1){ref-type="supplementary-material"}).

Rapid Chromatin Decompaction at GR-Bound Loci Can Occur without Transcription {#sec2.5}
-----------------------------------------------------------------------------

Chromatin at actively transcribed regions is generally less compact than at silenced regions ([@bib8], [@bib28]). Therefore, the decompaction we observed in response to Dex could be a consequence of, rather than causally linked to, transcriptional activation induced by GR. The rapidity of the response (within 5 min) and the persistence long after loss of GR binding ([Figure 4](#fig4){ref-type="fig"}E) and target gene inactivation, argue against the simple proposition that chromatin decompaction is associated with the act of transcription. However, to test this directly, we used α-amanitin to inhibit transcription by RNA Polymerase II. At *Tmod1*, where the induction by Dex is presumed to be indirect given the lack of GR binding ([Figures 2](#fig2){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}), pre-treatment of mBMDM with α-amanitin for 4 hr ablated the Dex-dependent changes in chromatin compaction ([Figures 5](#fig5){ref-type="fig"}A and 5B). Unexpectedly, α-amanitin also prevented detectable chromatin changes at *Klhl6/B3gnt5* ([Figure 5](#fig5){ref-type="fig"}C). This suggests either that this response is associated with transcription directly, or that it depends upon a labile regulator that decays, or is not produced, in the presence of the inhibitor ([@bib42]). Although the GR-bound enhancer at the *Klhl6/B3gnt5* locus has conserved GR and PU.1 consensus motifs, its GR-ChIP-seq peak is weaker than those at the *Fkbp5* and *Ms4xxx* loci. By contrast, Dex still induced significant chromatin decompaction at the *Fkbp5* ([Figures 5](#fig5){ref-type="fig"}D and 5F) and the *Ms4xxx* loci ([Figure 5](#fig5){ref-type="fig"}E) in the presence of α-amanitin, albeit with slightly delayed kinetics.Figure 5α-Amanitin Does Not Block Rapid Chromatin Unfolding at GR-Bound Loci(A) 3D DNA FISH images using probes across the *Tmod1* locus ([Figure 2](#fig2){ref-type="fig"}A) in nuclei from mBMDM that have been pretreated with 2.5 μg/mL α-amanitin for 4 hr, and then treated with 100 nM Dex for the indicated time. Scale bar represents 1 μm.(B) Inter-probe distances measured across *Tmod1* locus after pretreatment with α-amanitin for 4 hr and then treatment with 100 nM Dex for the indicated times. n = 120 for each dataset. ^∗^p \< 0.05, Wilcoxon rank sum.(C--E) Analogous to (B) but measured across the (C) *Klhl6/B3gnt5*, (D) *Fkbp5*, and (E) *Ms4xxx* loci.(F) 3D DNA FISH images using probes across the *Fkbp5* locus ([Figure 1](#fig1){ref-type="fig"}B) showing nuclei from mBMDMs that have been pretreated with 2.5 μg/mL α-amanitin for 4 hr, and then treated with 100 nM Dex for the indicated time. Scale bar represents 1 μm.

Discussion {#sec3}
==========

Single-cell imaging indicates that the binding of the GR, and associated coactivators that recruit chromatin remodeling complexes (GRIP1, BRG1), is dynamic and rapidly reversible ([@bib33]). In the present study, we have shown that GC produces very rapid changes to higher-order chromatin structure in macrophages at genomic sites where GR binds directly to DNA. Moreover, these changes persist for prolonged periods beyond the exposure to GC and do not depend upon the continuous presence of bound GR. It has been suggested that GR occupancy patterns in different cell types are predetermined by the distinctive baseline nucleosome accessibility patterns, a significant minority of which are then altered after GC treatment ([@bib20]). Local transient GR binding can promote subsequent binding of a variant GR to the same motif, a phenomenon referred to as "assisted loading" ([@bib48]).

Sustained chromatin reorganization in response to GR is not universal among target loci. The three genes tested that were induced only in mice, *Tns1*, *Tmod1*, and *Dst*, showed decompaction in response to Dex, but this was not sustained ([Figures 4](#fig4){ref-type="fig"}C and 4D), even though one of these (*Tns1*) has a GR-bound enhancer. The observation that most, but not all, inducible DNase I hypersensitive sites (DHSs) revert to the pre-stimulation state following GR stimulation ([@bib44]) suggests that these genes are in the majority.

The rapid chromatin decompaction we report at multiple GR-responsive loci is distinct from previous reports. Transient chromatin reorganization of the MMTV array detected following GC exposure could be prevented by blocking transcription ([@bib26]). However, lack of effect of α-amanitin at one-half of the loci we studied ([Figure 5](#fig5){ref-type="fig"}) suggests that transcription, per se, is not absolutely required for GR-induced decompaction.

At first sight, GR-induced chromatin decompaction at the *Fkbp5* locus conflicts with evidence of the formation of a compact loop domain in GC-responsive loci inferred in other systems ([@bib32], [@bib23]). However, chromosome conformation capture and FISH assays can give apparently discordant views of spatial genome organization ([@bib14], [@bib50]) and chromatin decompaction could still be permissive for transient, rather than stable, interactions between elements that can be captured by 3C methods. We cannot exclude that the decompaction we observe represents GC-induced dissolution of preformed chromatin loops. The action of the GR that we report here is reminiscent of large-scale chromatin decompaction induced by other nuclear hormone receptors: the ecdysone receptor, which induces visible chromatin decompaction (puffing) on *Drosophila* polytene chromosomes ([@bib45], [@bib37]), and the estrogen receptor ([@bib29], [@bib34]). The molecular details of these decompact chromatin structures are yet to be elucidated.

The loss of bound GR from target loci, despite the continued presence of the agonist, is reminiscent of the state of tolerance elicited in macrophages by lipopolysaccharide ([@bib38]). Most explanations for GC resistance in human patients are based upon the regulation of cellular responsiveness by extrinsic signals, such as inflammatory cytokines and bacterial products ([@bib3], [@bib9], [@bib40], [@bib39]). Consistent with that view, the response of the mouse BMDMs studied herein, and by others ([@bib30]), is acutely regulated by CSF-1 ([@bib17]). Persistent changes in chromatin structure, and a failure to rapidly return to the chromatin ground state that existed before GC exposure, suggest an additional mechanism that may contribute. Chromatin reorganization at key target loci in response to GR binding could alter the likelihood of those loci being regulated by a future stimulus. However, the effects of GC are often context specific ([@bib23]) and primary macrophages in culture evolve over time. It remains to be seen whether sustained chromatin decompaction can be observed in monocyte/macrophages derived from GC-treated patients and whether this is associated with either therapeutic efficacy, or the development of GC resistance.

Experimental Procedures {#sec4}
=======================

Ethics {#sec4.1}
------

Animals were cared for and managed within the Roslin Institute's Biological Research Facility following Institute guidelines. The Roslin Institute is committed to the highest standards of animal welfare and the University of Edinburgh is a signatory of the Concordat on Openness on Animals in Research in the UK. No interventions were performed on live animals for this research.

Cell Culture {#sec4.2}
------------

The 8- to 10-week male wild-type C57BL/6 mice were culled by cervical dislocation. Bone marrow was flushed from hindlimbs and then cultured in RPMI supplemented with penicillin/streptomycin, Glutamax (Invitrogen), and 10% fetal calf serum for 7 days in the presence of 10^4^ U/mL rhCSF-1. The resulting mBMDMs were replated onto Superfrost microscope slides (Thermo) at 5 × 10^5^ cells/mL and treated as indicated with 100 nM Dex (Sigma) or ethanol vehicle. Where described, cells were pre-treated with 2.5 μg/mL α-amanitin (Sigma) for 4 hr. Dex was washed out by removal of ligand-containing medium, washing gently once with fresh medium and then returning to culture in further fresh medium.

Chromatin Immunoprecipitation {#sec4.3}
-----------------------------

Antibodies used for chromatin immunoprecipitation of mouse GR were BuGR2 (1 μg/10^6^ cells; Thermo Fisher/Pierce) and rabbit IgG sc-2025 (Santa Cruz).

To prepare antibody-bound beads, 20 μL of Protein A Dynabeads (Invitrogen) per immunoprecipitation (IP) were washed once, and then diluted to 200 μL in block solution (1× PBS, 0.5% BSA, +2 μL of 0.1 M PMSF). Antibody was added and rotated for 3 hr at 4°C.

Cells were washed gently once with PBS, cross-linked in tissue culture plates with 1% formaldehyde/RPMI at room temperature for 10 min, and then quenched with 0.125 M glycine. Cells were detached by scraping in PBS, and then spun down (400 × *g*, 5 min, 4°C), resuspended, and counted. 10^6^ cells per IP were lysed for 15 min on ice in 1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, supplemented with protease inhibitors (Calbiochem), 1 mM DTT, and 0.2 mM PMSF (Sigma). The solution was diluted in IP dilution buffer (0.1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1) and sonicated using a Soniprep 150 to produce 300- to 500-bp average fragment sizes. Chromatin was spun for 10 min at 10,000 × *g* (4°C), and then supplemented with 20% Triton X-100 to 1%, and BSA (Sigma) to 50 μg/mL. Input aliquots were removed and stored at −20°C. Chromatin was then added to the antibody-bound Protein A Dynabeads (Life Technologies) and rotated overnight at 4°C. After binding, beads were washed 3 × 10 min each in the following: (1) 1% IP dilution buffer; (2) 1% Triton X-100/0.1% Na-deoxycholate/0.1% SDS, 50 mM HEPES, pH 7.9, 500 mM NaCl, 1 mM EDTA; and (3) 0.5% Na-deoxycholate/0.5% NP-40, 20 mM Tris-HCl, pH 8, 1 mM EDTA, and 250 mM LiCl. Chromatin was extracted at 37°C for 15 min on a vibrating platform in 100 μL of extraction buffer (0.1 M NaHCO~3~, 1% SDS). To reverse cross-links, samples were supplemented to 300 mM with NaCl, treated with RNaseA (20 mg) (Roche), and then incubated for ∼8 hr at 65°C. Proteinase K (40 μg) (Genaxxon) was added, and samples were incubated at 55°C for 1 hr. DNA was purified using the QIAquick PCR purification kit (QIAGEN). Real-time qPCR analysis to determine percent input bound at known GR target loci was carried out on a LightCycler 480 System using SYBR Green Master Mix (Roche).

Primers {#sec4.4}
-------

Primers are listed in [Table 1](#tbl1){ref-type="table"}.Table 1PrimersLocusSequenceFkbp5 −28 kb, forwardGAACACAGTGTCCCCCAGAGFkbp5 −28 kb, reverseCAGGAGAGGAGGAGAGGGTCFkbp5 promoter, forwardTTTGCATCTCCGCCTCTTCAFkbp5 promoter, reverseTCCTCCATCCCTCTTCTCCGFkbp5 +65 kb, forwardGCCAAGTTCAGCTGTGCAATFkbp5 +65 kb, reverseTGCCAGCCACATTCAGAACATns1, forwardGCAGTTTGGAGCCAAAAAGACCTns1, reverseTGGGTCTGAGCAATTCCAGTTCMs4xxx, forwardTGTTAATGGTGGCGTGAGAGTGMs4xxx, reverseATAAGACGTGGTACTGCCTGAGActb promoter, forwardCTAGCCACGAGAGAGCGAAGActb promoter, reverseCGCGAGCACAGCTTCTTT

3D DNA FISH {#sec4.5}
-----------

Paraformaldehyde (pFA)-fixed cells were permeabilized in 0.5% Triton X-100, washed in PBS, and stored at −80°C. 3D-FISH was carried out as previously described ([@bib12]). Slides were imaged and analyzed as described previously ([@bib49]). The statistical significance of differences in n (values in figure legends) measured inter-probe distances was assessed using the nonparametric Wilcoxon rank sum test in R. Fosmid clones were from BACPAC Resource Center (Oakland, CA) and are listed in [Table 2](#tbl2){ref-type="table"}.Table 2Fosmid ClonesLocusWhitehead Fosmid NameMap Position (Chromosome: Sequence Range)Fkbp5WI1-1951C9chr17:28621896--28660104Fkbp5WI1-980F19chr17:28504480--28545426Tmod1WI1-2441L4chr4:46121795--46162130Tmod1WI1-552C3chr4:45995494--46038724Ms4xxxWI1-1714F1chr19:11344410--11380699Ms4xxxWI1-794B24chr19:11607184--11647412Klhl6WI1-593E13chr16:19778756--19815279Klhl6WI1-1540E20chr16:19986135--20022250DstWI1-2074K18chr1:34007075--34047561DstWI1-1520P06chr1:34311167--34352486Tns1WI1-2221B20chr1:74136897--74174845Tns1WI1-501O4chr1:73867180--73908234

Data and Software Availability {#app1}
==============================

The accession number for the microarray and ChIP sequencing data reported in this study (from [@bib22]) is GEO: [GSE61881](ncbi-geo:GSE61881){#intref0010}.
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